Lupin
slipped over 13% to Rs1294.05, after reports suggested that it has received a
Form 483 (observation letter) from US drug regulator, USFDA for its Mandideep
manufacturing facility.
Lupin's
active pharmaceutical ingredient ( API) and formulations units of Mandideep
manufacturing facility in Madhya Pradesh have reportedly received two
observations each after the facility was inspected by United States Food &
Drug Administration ( USFDA) between February 08, to February 19, 2016.
Ashok Leyland sells 0.55% stake in Indusind Bank
Ashok
Leyland has sold 0.55% stake in Indusind Bank for Rs300 crore. The proceeds are
likely to be utilized to reduce debt.
The
stock opened at Rs105.40 marking days low at Rs105.05 with an intraday high of
Rs106.50 and is currently trading at Rs105.45 up by 0.67% on NSE so far.
LIC ups stake in IDBI Bank to 14.3%
IDBI
Bank has allotted 15.8 crore equity shares, equivalent to 7.16% stake for Rs850
crore, on preferential basis to Life Insurance Corporation of India (LIC),
which now holds over 14.3% stake in IDBI Bank.
The
allotment of shares is part of IDBI Bank's plan to offload government
shareholding as part of its privatization move.
Cadila receives USFDA nod to market Acyclovir tablets
Cadila receives nod from USFDA to market Acyclovir tablets
(manufacturing at Ahmedabad SEZ), used in treatment of AIDS – Sentimentally
positive.
Torrent Power signs contract with WTG group
Torrent
Power has entered into a contract with a leading WTG manufacturing group for
development of the 197.40 MW Wind Power Project across three sites in Kutch and
Bhavnagar, Gujarat.
This
Project is expected to be commissioned progressively by March 2017 and shall
have off take arrangements for fulfilment of Renewable Power Purchase
Obligations (RPO).
Get real time advice for Intraday Trading Tips , Share Market Live , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates .
0 comments:
Post a Comment